The budding yeast, *Saccharomyces cerevisiae*, can respond to environmental cues with numerous morphological switches and developmental phenotypes that likely increase fitness in naturally occurring conditions ([@bib59]). One such phenotype, filamentous growth, is thought to be a foraging strategy in response to nutrient stress. It is characterized by elongated cell morphology, unipolar budding, incomplete separation of mother-daughter cells, and substrate invasion ([@bib15]). In diploid cells it is primarily induced by nitrogen limitation and known as pseudohyphal growth ([Figure 1](#fig1){ref-type="fig"}), while a similar though distinct response is triggered by carbon source limitation in haploid cells and is known as haploid invasive growth ([@bib8], [@bib7]).

![Pseudohyphal growth. Images depict: a small colony with pseudohyphae surrounding it (A), a close-up of a colony perimeter (B), and an image of the same perimeter in a different focal plane showing the pseudohyphae growing into the agar (C). Scale bar represents 200 μm. To obtain images, strain YJM1439 was streaked on a SLAD plate and grown for 6 days.](1533f1){#fig1}

In a lab strain, Σ1278b, haploid and diploid filamentous growth were shown to occur in response to the aromatic alcohols phenylethanol and tryptophol ([@bib4]). Production of these compounds is dependent on cell density and regulated through positive feedback, suggesting they may function as auto-inducing, quorum-sensing (QS) molecules. The human commensal and opportunistic pathogen, *Candida albicans*, can also undergo a morphological switch to a form of filamentous growth in response to QS molecules, which may be related to its ability to be pathogenic ([@bib21], [@bib28], [@bib44], [@bib5], [@bib1], [@bib36]). Parts of the signaling pathway are evolutionarily conserved ([@bib31], [@bib3]); thus, filamentous growth may represent a general, social, yeast survival strategy in the natural environment ([@bib58]).

In *S. cerevisiae*, filamentous growth is regulated by multiple evolutionarily conserved, pleiotropic signaling networks, including the glucose-sensing RAS/cAMP-PKA and SNF pathways, the nutrient-sensing TOR pathway, and the filamentous growth MAPK pathway (reviewed in [@bib18], [@bib7]). These signaling pathways converge to regulate the transcription of *[FLO11](http://www.yeastgenome.org/locus/S000001458/overview)*, which encodes a cell wall flocculin required for multiple *S. cerevisiae* developmental phenotypes, including filamentous growth ([@bib26], [@bib32], [@bib41], [@bib46], [@bib2], [@bib6]). In lab backgrounds, deletion ([@bib23], [@bib47]) and overexpression collections ([@bib50]), as well as QTL mapping of genetic crosses ([@bib52], [@bib38]), have identified hundreds of genes contributing to the phenotype.

The extent of phenotypic and genetic variation in filamentous growth in natural populations is still under-explored, as studies of this phenotype are dominated by the lab strain Σ1278b. Previous work has shown that in comparison to natural isolates, lab strains are often genetically and phenotypically atypical ([@bib56]). Thus, incorporating environmental isolates into genetic research broadens the scope of our understanding, both in how genetic variation modulates traits and how phenotypic variation manifests in natural populations ([@bib14]). The present study makes use of the 100-genomes collection, a panel of yeasts from subpopulations around the world and from a broad diversity of ecological niches, including fermentation reactions, clinical patients, and soil, plant and insect samples ([@bib53]), to explore natural variation in filamentous growth and response to QS compounds.

*Saccharomyces* yeasts are presumed diploid in nature ([@bib43]); therefore, the focus of the present study is the diploid filamentous growth response, pseudohyphal growth (psh). Most studies of psh use agar invasion as a quantitative metric for the phenotype, while the appearance of "pseudohyphae" around a colony ([Figure 1](#fig1){ref-type="fig"}) is assessed qualitatively. Using these metrics, ([@bib34]) found variation in a sample of environmental isolates, and Hope and Dunham (2014) found variation in the SGRP collection ([@bib30]). Less is known about variation in psh response to QS molecules, and to our knowledge, no systematic surveys have been done.

Using a quantitative measure of the amount of pseudohyphae to estimate psh, which we call the "filamentous index", we found a large amount of variation in the 100-genomes collection. When the strains were classified by the broad ecological category from which they were isolated, fermentation isolates exhibited a slightly elevated filamentous index compared to other ecological niches; however, this result appeared driven by a single isolate. When strains were classified by their subpopulation membership ([Figure 2](#fig2){ref-type="fig"}), which took phylogenetic history into consideration, isolates from the West African subpopulation had an elevated filamentous index compared to other subpopulations. Surprisingly, we find that in most isolates, addition of either phenylethanol or tryptophol to the medium had a negligible effect on psh, with a few strain-specific exceptions.

![Population structure of the 100-genomes panel supplemented with strain YJM311, as inferred by the program *structure*. Following the analysis of [@bib53], each vertical line represents an individual strain with its fractional ancestry of K = 6 subpopulations represented by colors: green (North American), orange (Malaysian), red (West African), purple (Sake), blue (European/wine), and gray (human associated). Strains were assigned membership based on a threshold of \>60% ancestry in a subpopulation, except for mosaic strains which had less than 60% ancestry in any other subpopulation.](1533f2){#fig2}

As most genomic studies focus on Σ1278b, the present study also examined the amount of naturally occurring, segregating genetic variation for psh using a mapping population of segregants from YJM311 as a proxy. This strain is a highly-heterozygous clinical isolate ([@bib19]) belonging to the "mosaic" subpopulation that contains genetic variation associated with each of the other major *S. cerevisiae* subpopulations ([Figure 2](#fig2){ref-type="fig"}). As such, it represents an ideal representative genetic background to investigate. We find that this single background contains enough genetic variation to recapitulate the range of phenotypes found in the 100-genomes panel. Using a bulk-segregant analysis, we find 5 genomic regions with major peaks significantly associated with the traits. Numerous genes that have been shown to influence the trait in Σ1278b are located within the peaks, and could therefore plausibly harbor the causative alleles.

Overall, our results indicate that there is an extensive amount of phenotypic and genetic variation in a well-studied developmental phenotype in environmental isolates, and that the response to aromatic alcohols may be a more limited, strain-specific effect. The relevance of this phenotype in the natural environment remains unknown, as no single broad ecological category appeared to be strongly associated with the trait, while subpopulation membership did seem to be associated with psh ability. Our results highlight the importance of complementing studies in lab strains with numerous genetic backgrounds isolated from the environment.

Materials and Methods {#s1}
=====================

Strains {#s2}
-------

96 strains from the 100-genomes collection ([@bib53]) were phenotyped for psh (Table S1); these diploid strains are derived from single spores from original environmental isolates. Three of the strains, wells H8, H9, and H10, are not *S. cerevisiae* and were not included the downstream analyses. YJM311, a homothallic, clinical isolate ([@bib19]), was used to conduct a bulk segregant analysis (BSA). For a different study in our lab, the original diploid isolate was transformed to express a *PGK1-mCherry-KanMX* fusion (HMY7) and used to generate an F5 mapping population. This mapping population was used in the present study.

Media {#s3}
-----

Yeast were grown in liquid YPD (1% yeast extract, 2% peptone, and 2% dextrose). Psh was induced on 4X synthetic low-ammonium dextrose (SLAD; 0.68% yeast nitrogen base w/o amino acids or ammonium sulfate, 2% dextrose, 50 μmol ammonium sulfate, and 2% agar) ([@bib4]) and when appropriate, supplemented with phenylethanol (PheOH; Sigma-Aldrich, 77861) or Tryptophol (TrpOH; Sigma-Aldrich, T90301) dissolved in DMSO, added to a final concentration of 100 μmol. OmniTrays were poured two days before use in an assay. Sporulation of the mapping population was induced on sporulation medium (2% potassium acetate, 2% agar).

Generation of an F5 Mapping Population {#s4}
--------------------------------------

HMY7 was cycled through 4 rounds of sporulation, digestion, mating and growth (described in FileS1). At the end of the last cycle, spores were plated to a density of ∼100 colonies per plate and 360 segregants were isolated and phenotyped. Each colony was presumed diploid due to self-mating.

Sequencing and Bulk Segregant Analysis {#s5}
--------------------------------------

Segregants with the highest and lowest filamentous indices, as well as lowest variance among replicate measurements, were chosen for further analysis. After re-assaying to verify psh, 22 segregants were identified for each pool. Segregants were grown to saturation in YPD in a 96-well plate, then combined for total genomic DNA extraction with the MasterPure Yeast DNA Purification Kit. Bulk pools were sent to the University of Georgia Genomics and Bioinformatics core for KAPA library prep and paired-end 150bp sequencing on an Illumina MiSeq Micro platform for an average coverage of ∼55-fold. DNA from HMY7 was previously sequenced at the Duke Genome Sequencing Core on an Illumina HiSeq 2000 instrument with single-end 50bp reads to an average coverage of 110-fold.

Reads from the bulk pools were aligned to the HMY7 genome (Supplementary Text) using BWA ([@bib29]), and SNPs were called using Freebayes ([@bib13]) with settings for a pooled population. SNPs were filtered for quality and coverage. Bulk pools were compared using the R-package QTLseqr ([@bib37]), which implements the smoothed-G statistics of ([@bib35]).

YJM311 Subpopulation Membership {#s6}
-------------------------------

In order to assign YJM311 to an *S. cerevisiae* subpopulation, the fixed SNPs from its genome were included in the dataset from the 100-genomes collection and analyzed using the program *structure* V 2.3.4 ([@bib42]) following the specifications of [@bib53]. Briefly, the large set of SNPs found across the complete strain panel was filtered and sampled to create four independent sets of ∼1,200 SNPs in low linkage disequilibrium and representing the distribution of minor allele frequencies (generously provided by D. Skelley). Once YJM311 was incorporated, each of the four data sets was run three times using the linkage model ([@bib11]) with a burn-in of 200,000 iterations and 1,000,000 iterations of MCMC, and K = 6 groups. The results from the 12 independent runs were compared using *CLUMMP* V 1.1.2 ([@bib22]) and visualized using *distruct* V 1.1 ([@bib45]).

Pseudohyphal Growth {#s7}
-------------------

For the 100-genomes strains, YPD cultures were grown to saturation (∼24 hr) in a 96-well plate and ∼2 μl per well was transferred to OmniTrays (Nunc 264728) using a 96-pin multi-blot replicator (V&P Scientific no. VP408FP6). For a given assay, a single 96-well plate was pinned to four replicates of three different media types (SLAD, SLAD + PheOH, SLAD + TrpOH). OmniTrays were wrapped with parafilm to prevent drying and incubated at 30C for one week. After incubation, trays were scanned on an Epson Expression 11000 XL scanner, which produced RGB color images with 1200 dpi. For the F5 mapping population, the same procedure was implemented for the 360 segregrants, but only SLAD + PheOH medium was used and with only two replicates per assay. For both the 100-genomes panel and the mapping population, the entire assay was repeated three times.

Follow-up experiments required streaking freezer cultures onto YPD agar, then streaking isolated colonies onto SLAD agar (+ PheOH or TrpOH, when appropriate) and incubating at 30C for 5 days before imaging.

Image Analysis {#s8}
--------------

The scanned images were processed using a custom Python script (referred to here as "Eclipse"; Supplementary Material) that utilized the skimage package ([@bib55]) to read the color qualities of individual pixels. Eclipse discriminated between outer-colony filamentous growth and the inner colony, and reported the ratio of the two, a metric inspired by [@bib54].

Image Processing {#s9}
----------------

It was necessary to identify the color thresholds that designated the colony ring exclusively as white, the filamentous growth as gray, and the background as a separate entity. The image of the entire OmniTray was used to establish the values that best separated the parts of the colony; these values were then used to process the 96 cropped images representing individual colonies. Cracks, smudges, light reflection, and localized contamination interfered with image processing. In these cases, the individual colony images were examined and cropped to exclude trouble spots or dropped from analysis. For YJM311, only segregants that were consistently high-psh and low-psh were of interest for pooling in the bulk segregant analysis. We therefore manually inspected all images and dropped measurements that did not appear to accurately reflect the level of filamentation in the image (assessed qualitatively). This was not done for the panel of environmental isolates as we did not want to introduce bias, and because variation in the measurements was of interest for the downstream analysis.

Statistics {#s10}
----------

The data from the 100-genomes panel was analyzed in JMP 11.2.0 using an ANOVA framework with three different models. First, no group identity was assigned to the strains. The following model was fitted to the data: Y = μ + Treatment + Strain + Strain x Treatment + Assay + Assay x Treatment + Strain x Assay + Strain x Assay x Treatment. Strain and treatment were considered fixed effects, while assay was considered a random effect. Next, strains were assigned to an ecological niche, which was considered a fixed effect, and the following model was fitted to the data: Y = μ + Niche + Treatment + Strain\[Niche\] + Assay + Niche x Treatment + Strain x Treatment\[Niche\] + Assay x Treatment + Assay x Niche + Strain x Assay\[Niche\] + Strain x Assay x Treatment\[Niche\]. Brackets denote nested effects. Finally, strains were assigned to a subpopulation and the data were fitted to a model similar to the previous one. The data from the YJM311 segregants were transformed into z-scores for each plate; these values were used to help identify the strains with highest and lowest filamentous index.

Data Availability {#s11}
-----------------

Environmental strains from the 100-genomes collection are available upon request, as well as from the authors of the original study ([@bib53]). Table S1 lists all the isolates along with the filamentous indices extracted from the images. HMY7 and all its segregants are available upon request; table S2 lists all the filamentous indices. Text of the Python program is available as a supplementary file (Eclipse.py). Raw reads have been deposited in the Short Read Archive (<https://www.ncbi.nlm.nih.gov/sra>) in BioProject PRJNA525878; sample numbers for HMY7, the high, and low bulk pools are SAMN11079405, SAMN11079406, and SAMN11079407, respectively. Supplemental material available at Figshare: <https://doi.org/10.25387/g3.7822523>.

Results {#s12}
=======

In order to investigate natural variation in psh and its induction by the QS compounds PheOH and TrpOH, the first 96 strains of the 100-genomes panel were plated on nitrogen-limiting medium using a pinning tool. [Figure 3](#fig3){ref-type="fig"} shows the typical structure of a psh colony formed from pinning. Such colonies contain a white "ring" around the inner part where the pinner left cells; this ring separates the gray filamentous growth from the rest of the colony. Our image analysis pipeline located the highest and lowest values of the white ring on both the vertical and horizontal axes, which established a major and minor axis for the ring, and thus mapped out its location as an ellipse. This ellipse was used to "eclipse" all pixels inside of it, demarcating the inner colony. These eclipsed pixels were separated from the non-eclipsed pixels and the ratio of the two was calculated. The ratio, or "filamentous index", represents a rough quantitative measure of the filamentous growth of the colony; sample values are shown in [Figure 3](#fig3){ref-type="fig"}.

![Image processing pipeline. First column: three sample colonies from an Omnitray, which was blotted with 1.58 mm pins; in order, strains YJM984, YJM1336, and YJM1341, derived from 96-112, a clinical strain, M28s2, a European wine strain, and NRRL Y-12637, a South African wine strain, respectively. Second column: original images processed to differentiate white ring, filamentous growth, and background. Third column: inner part of the colony separated and pseudohyphal pixels counted to generate the filamentous index listed on the right.](1533f3){#fig3}

Across 29 agar trays in three independent assays, 2516 colonies were scored for psh. In the complete data set, the mean filamentous index was 13.01 and the median was 12. These data were analyzed using three linear models. The first did not assign any group identity to the strains and was used to investigate the variation among strains. The second model assigned a broad ecological category to the strains and tested for an effect of niche. The third and final model assigned subpopulation membership to the strains and tested for an effect of this phylogenetic history.

Variation in Pseudohyphal Growth {#s13}
--------------------------------

Of the ∼2500 colonies that were imaged and scored, 895 were grown without the addition of quorum sensing compounds and represent the base level of psh for the strains; the mean filamentous index was 13.29. Overall, there was a wide range of variation in the panel (black data points and distribution in [Figure 4A,B](#fig4){ref-type="fig"}) with a maximum average filamentous index of 33.3 for YJM1439 (derived from NCYC110), a ginger beer strain from West Africa, and a minimum average filamentous index of 7.5 for YJM1433 (derived from Yllc17_E5), a wine strain from France.

![Psh for the 100-genomes panel and the YJM311 mapping population. (A) and (C) plot average filamentous index for individual strains or segregants (+/− 2 s.e.m.), respectively, and were ordered based on their filamentous index. Panel A also contains the means for the subpopulations; points not connected by the same letter are significantly different. Panels (B) and (D) represent population distributions. In (A-B), black is control, red is PheOH treatment, and blue is tryptophol treatment. In (C-D), green is the high pool and orange is the low pool.](1533f4){#fig4}

In all three linear models fitted to the data, the strain effect was significant ([Table 1](#t1){ref-type="table"}). Individual strains with significant parameter estimates (both above and below the mean) are listed in [Table 2](#t2){ref-type="table"}; strains that were significant in all three models are bolded. While the filamentous index only provides an approximate measure of psh, the behavior of individual strains appears to have been captured well, as the random effects in the model that were associated with replicate assays contributed little of the variation (a total of ∼15% among all the random effects).

###### Results of the 100 Genomes pseudohyphal and quorum sensing analyses. *a*-Degrees of freedom are estimates due to different numbers of samples in each category and to incomplete samples for some strains (*i.e.*, images dropped from analysis)

  Source                               DF ratio     *p* value   Random Effects   \% Total Variance                     
  ------------------------------------ ------------ ----------- ---------------- ------------------------------------- ------
  **Model 1: No Group Membership**                                                                                     
  Treatment                            2, 4.03      2.016       0.2473           Assay                                 0.0
  Strain                               92, 176.7    10.850      **\<0.0001**     Treatment x Assay                     8.9
  Treatment\*Strain                    184, 343.4   0.8994      0.7888           Strain x Assay                        5.4
                                                                                 Strain x Assay x Treatment            0
                                                                                 Residual                              85.7
  **Model 2: Niche Membership**                                                                                        
  Niche                                3, 6.33      4.35        0.0562           Assay                                 0.0
  Treatment                            2, 4.41      1.946       0.2478           Treatment x Assay                     8.8
  Strain\[Niche\]                      89, 170.2    11.38       **\<0.0001**     Niche x Assay                         1.0
  Treatment x Niche                    6, 358.7     0.482       0.8217           Strain x Assay\[Niche\]               5.2
  Strain x Treatment\[Niche\]          178, 343.3   0.911       0.7574           Strain x Assay x Treatment\[Niche\]   0
                                                                                 Residual                              85.0
  **Model 3: Population Membership**                                                                                   
  Population                           5, 6.93      23.73       **0.0003**       Assay                                 0.0
  Treatment                            2, 5.13      1.17        0.2857           Treatment x Assay                     8.86
  Strain\[Population\]                 87, 167.3    9.74        **\<0.0001**     Population x Assay                    0.03
  Treatment x Population               10, 360.5    0.438       0.9274           Strain x Assay\[Population\]          5.92
  Strain x Treatment\[Pop\]            174, 344.1   0.926       0.7147           Strain x Assay x Treatment\[Pop\]     0
                                                                Residual         85.19                                 

###### Parameter estimates for strains that were significant in at least one of the linear models

  Individual Strains                                                                                                   
  -------------------- -------------------- ------- ---------- ---------- -------- ---------- ---------------- ------- ----------
  G10                  **NCYC110**          20.21   \<0.0001   Ferment    19.08    \<0.0001   West African     11.43   \<0.0001
  D2                   **NRRL Y-10988**     9.38    \<0.0001   Clinical   9.72     \<0.0001   Mosaic           9.47    \<0.0001
  F1                   **NRRL Y-12637**     9.15    \<0.0001   Ferment    8.02     \<0.0001   European         9.30    \<0.0001
  B11                  **R93-1871**         8.20    \<0.0001   Clinical   8.52     \<0.0001   Mosaic           8.30    \<0.0001
  E11                  **M28s2**            6.51    \<0.0001   Ferment    5.38     \<0.0001   European         6.66    \<0.0001
  A1                   **YJM128**           6.02    \<0.0001   Clinical   6.36     \<0.0001   Mosaic           6.11    \<0.0001
  D10                  **NRRL Y-1532**      4.55    \<0.0001   Plant      5.17     \<0.0001   European         4.69    \<0.0001
  C12                  SK1                  4.17    0.0003     Lab        4.32     \<0.0001   West African     −1.14   0.2653
  A2                   **NCYC 431**         4.17    0.001      Ferment    3.04     0.0127     European         4.31    0.0006
  H4                   **DBVPG1853**        3.57    0.0018     Ferment    2.44     0.0255     European         3.72    0.0011
  H5                   **NRRL Y-581**       3.55    0.0016     Ferment    2.41     0.0249     European         3.69    0.001
  A5                   **CBS 1227**         2.98    0.0083     Clinical   3.31     0.0025     European         3.12    0.0053
  D11                  NRRL Y-1546          2.98    0.0086     Ferment    1.84     0.0895     West African     −2.34   0.0223
  A3                   NCYC 914             2.89    0.0178     Ferment    1.78     0.1284     European         3.032   0.0123
  F7                   **NRRL Y-11857**     2.58    0.0421     Plant      3.22     0.0084     Mosaic           2.68    0.0336
  D4                   **MMRL 125**         2.45    0.0398     Clinical   2.74     0.0177     Mosaic           2.54    0.0314
  F6                   **NRRL Y-5511**      2.40    0.0309     Plant      3.02     0.0049     European         2.55    0.0213
  D9                   **NRRL Y-35**        2.40    0.0312     Plant      3.02     0.0049     European         2.55    0.0215
  G1                   NRRL YB-4081         2.25    0.0532     Plant      2.89     0.0100     Mosaic           2.35    0.0425
  B1                   B70302(b)            2.05    0.0828     Clinical   2.38     0.0387     Mosaic           2.15    0.0673
  A4                   NCYC 762             1.50    0.2336     Ferment    0.39     0.7461     West African     −3.81   0.0007
  G4                   NRRL Y-268           −1.09   0.3258     Ferment    −2.23    0.037      European         −0.94   0.3903
  E10                  M1-2                 −1.19   0.2852     Ferment    −2.34    0.0302     European         −1.05   0.3437
  G5                   NRRL YB-2541         −1.63   0.1426     Ferment    −2.78    0.0098     European         −1.48   0.178
  H3                   Y12                  −1.97   0.0766     Ferment    −3.12    0.0038     Sake             0.29    0.7452
  A6                   CBS 2910             −2.24   0.0443     Clinical   −1.91    0.0769     European         −2.09   0.0578
  B12                  R93-1017             −2.25   0.0447     Clinical   −1.91    0.0792     Mosaic           −2.16   0.053
  C4                   96-101               −2.26   0.0424     Clinical   −1.92    0.0743     European         −2.11   0.0555
  F11                  NRRL Y-17447         −2.28   0.0405     Plant      −1.66    0.1193     Sake             −0.02   0.9851
  G7                   NRRL YB-2625         −2.29   0.0416     Plant      −1.68    0.1175     Mosaic           −2.19   0.0494
  E4                   **Sigma1278b**       −2.29   0.0394     Lab        −2.15    0.0169     Mosaic           −2.20   0.0469
  A7                   CBS 2807             −2.30   0.0777     Ferment    −3.41    0.007      European         −2.16   0.0951
  B8                   **Y55**              −2.31   0.0431     Lab        −2.17    0.0172     West African     −7.62   \<0.0001
  E2                   YPS134               −2.34   0.036      Plant      −1.72    0.1067     North American   −0.41   0.653
  E5                   **RM11**             −2.38   0.0324     Ferment    −3.53    0.0011     European         −2.24   0.0427
  G12                  UWOPS83-787.3        −2.38   0.0323     Plant      −1.76    0.0978     Mosaic           −2.29   0.0387
  D12                  NRRL Y-6673          −2.40   0.0309     Plant      −1.79    0.0932     European         −2.26   0.0409
  F4                   **NRRL Y-747**       −2.43   0.029      Ferment    −3.58    0.0010     European         −2.29   0.0384
  F5                   **NRRL YB-427**      −2.45   0.0277     Ferment    −3.60    0.0009     Mosaic           −2.36   0.0332
  C5                   **96-109**           −2.50   0.0248     Clinical   −2.16    0.0449     European         −2.36   0.033
  F10                  NRRL Y-12769         −2.54   0.0238     Ferment    −3.68    0.0008     Sake             −0.28   0.7605
  H2                   273614N              −2.57   0.0312     Clinical   −2.22    0.0551     European         −2.42   0.0403
  E8                   **UM400**            −2.65   0.0174     Clinical   −2.32    0.0319     Mosaic           −2.56   0.021
  E7                   **NRRL Y-961**       −2.85   0.0106     Clinical   −2.52    0.0198     Mosaic           −2.76   0.0129
  G3                   **NRRL YB-4449**     −3.11   0.0055     Plant      −2.50    0.0197     Mosaic           −3.01   0.0067
  D7                   **UCD-FST 08-200**   −3.13   0.0052     Clinical   −2.79    0.0100     Mosaic           −3.04   0.0064
  F9                   **NRRL Y-12758**     −3.19   0.0044     Ferment    −4.34    \<0.0001   European         −3.05   0.0061
  C7                   **96-112**           −3.29   0.0034     Clinical   −2.94    0.0066     European         −3.14   0.0047
  C3                   **96-100**           −3.37   0.0026     Clinical   −3.03    0.0052     European         −3.23   0.0037
  F3                   **NRRL Y-234**       −3.40   0.0024     Ferment    −4.55    \<0.0001   European         −3.26   0.0034
  B9                   **YJM653**           −3.76   0.0012     Clinical   −3.44    0.0022     Mosaic           −3.66   0.0015
  ^1^H                 **UWOPS05-227.2**    −4.30   0.0003     Plant      −3.68    0.0012     Malaysian        na      na
  D6                   **UCD-FST 08-199**   −4.38   0.0001     Clinical   −4.04    0.0003     Mosaic           −4.28   0.0002
  B2                   **B68019c**          −5.13   \<0.0001   Clinical   −4.79    \<0.0001   European         −4.98   \<0.0001
  G8                   **Yllc17_E5**        −9.18   \<0.0001   Ferment    −10.33   \<0.0001   European         −9.04   \<0.0001

  **Group Effects**                                                                                                    
  ------------------- ----------- -------- -------------------- ----------- -------- -- ------------------ ----------- ----------
  Clinical            −0.328519   0.3636   European             0.4255585   0.1938                                     
  **Ferment**         1.1219714   0.0151   **Malaysian**        −3.732617   0.0002                                     
  Lab                 −0.155135   0.7775   Mosaic               0.4744595   0.1495                                     
  Plant               −0.638317   0.111    **North American**   −1.354773   0.0249                                     
                                           **Sake**             −1.693082   0.005                                      
                                                                                        **West African**   5.8804544   \<0.0001

\- Strains that were significant in all three models are in bold.

\- The parameter estimates are from a linear model and indicate the amount a given strain is above or below the estimate of the intercept. The intercepts for the models are as follows: no group membership- 13.16, niche- 13.17, population- 12.59. In the models with either a niche or population classification, the strains were nested within their group. The estimate for a strain is therefore the combination of the intercept, the strain parameter, and the group parameter.

\- A *p* value of less than 0.05 indicates a significant difference from 0.

In the second linear model, strains were divided into four ecological categories based on where they were isolated: fermentation, clinical, plant, and lab environments. The lab category represents strains that have been propagated in the lab environment for many years and may no longer represent the characteristics of the niche from which they were isolated, and includes the model strain Σ1278b. Each of the niche categories contained a wide range of variation in psh (Figure S2). The effect of niche was on the margin of significance in the linear model (*P* = 0.056); a *post hoc* Tukey's Honestly Significant Difference test found fermentation to be higher than the other categories (mean filamentous index of 14.29 compared to 13.01, 12.83, and 12.52 for lab, clinical, and plant, respectively). However, if the strain with the most abundant pseudohyphae, YJM1439, is removed from the analysis, the niche effect is no longer significant (*P* = 0.185; fermentation mean = 13.50), suggesting the effect is tenuous.

In the third and final linear model, strains were assigned membership to a subpopulation (based on the *structure* analysis) ([Figures 4A,B](#fig4){ref-type="fig"}). Most of the strains fell in the European/wine and mosaic categories, with the Malaysian subpopulation represented by a single strain; therefore the results for this analysis should be interpreted with caution. The effect of population was significant in the model (*P* = 0.0003). A *post hoc* Tukey's Honestly Significant Difference test found the West African subpopulation to have a higher filamentous index than the other categories ([Figure 4A](#fig4){ref-type="fig"}, last panel). The West African subpopulation contained YJM1439, the strain with the highest filamentous index. When this strain was removed, the West African subpopulation remained significantly higher than the others (mean = 14.77 compared to 18.47 with YJM1439). Thus, for at least one subpopulation, membership may be an important predictor for psh.

Variation in Response to Quorum Sensing Compounds {#s14}
-------------------------------------------------

Of the colonies that were imaged and scored, 670 were grown in medium supplemented with PheOH and 951 were grown in medium supplemented with TrpOH; these produced a mean filamentous index of 14.20 and 11.89 respectively. Surprisingly, there was no overall effect of the addition of QS compounds (*P* = 0.2473 in the model with no group identity, *P* = 0.2478 in the niche model, and *P* = 0.2857 in the population model). Two strains significantly increased psh in response to PheOH in all three models and a different two strains increased in response to TrpOH. However, two strains also significantly *decreased* psh in the presence of one or both of the compounds ([Table 3](#t3){ref-type="table"}). Even for the strains that appeared to respond significantly, the effect sizes were small (on the order of 2-3 in the filamentous index). Mostly, PheOH and TrpOH appeared to have little to no effect on psh.

###### Parameter estimates for response to the QS treatments

            Individual Strain x Treatment Effects                                                                                                                          
  --------- --------------------------------------- ------------- ----------------- ----------- ----------- ----------------- ----------- -------------- ----------------- -----------
  **D11**   **yes**                                 **Control**   4.08              0.0008      Ferment     4.23              0.0005      West African   3.64              0.001
  **G8**    --                                      **Control**   3.48              0.0049      Ferment     3.65              0.0029      European       3.31              0.0071
  D10       no                                      Control       2.37              0.0429      Plant       2.21              0.0554      European       2.20              0.0588
  F6        --                                      Control       2.34              0.0454      Plant       2.18              0.0588      European       2.17              0.0622
  E9        --                                      Control       2.28              0.051       Clinical    2.24              0.0539      Mosaic         2.48              0.0335
  G12       no                                      Control       −2.12             0.0694      Plant       −2.29             0.0472      Mosaic         −1.93             0.0963
  H5        **yes**                                 Control       −2.24             0.0559      Ferment     −2.09             0.0709      European       −2.41             0.038
  **A9**    **yes**                                 **Phe**       5.34              0.0009      Clinical    5.15              0.0012      Mosaic         5.20              0.0011
  **F1**    no                                      **Phe**       3.62              0.0046      Ferment     3.66              0.0039      European       3.76              0.0031
  D1        no                                      Phe           2.63              0.0474      Clinical    2.52              0.056       European       2.76              0.0359
  G12       no                                      Phe           2.35              0.0591      Plant       2.63              0.0321      Mosaic         2.20              0.0754
  **G8**    --                                      **Phe**       −3.27             0.0106      Ferment     −3.26             0.0099      European       −3.14             0.0135
  **A2**    **yes**                                 **Trp**       3.08              0.0236      Ferment     2.89              0.0306      European       3.13              0.0206
  **H3**    no                                      **Trp**       2.75              0.016       Ferment     2.57              0.023       Sake           2.36              0.0124
  G11       no                                      Trp           2.29              0.0452      Plant       2.17              0.0536      Mosaic         2.24              0.0481
  **F1**    no                                      **Trp**       −3.00             0.0154      Ferment     −3.18             0.0092      European       −2.95             0.0161
  **D11**   **yes**                                 **Trp**       −3.34             0.0039      Ferment     −3.53             0.002       West African   −3.17             0.0026
            **Treatment Effects**                                                                                                                                          
                                                    Treatment     Effect Estimate   *p* value   Treatment   Effect Estimate   *p* value   Treatment      Effect Estimate   *p* value
                                                    Control       0.095             0.9034      Control     0.023             0.9773      Control        0.040             0.9608
                                                    Phe           1.223             0.1694      Phe         1.268             0.1588      Phe            1.194             0.1854
                                                    Trp           −1.318            0.1455      Trp         −1.290            0.1526      Trp            −1.234            0.171

\- Strains that were significant in all three models are in bold.

-Strains whose phenotypic response was investigated via streaking have a yes or no to indicate whether the predicted response was detectable; "-" indicates the strain was not streaked.

\- A *p* value of less than 0.05 indicates a significant difference from 0.

Comparison to Streaked Colonies {#s15}
-------------------------------

In order to verify the results from the high throughput assay, a selection of 10 strains that appeared to respond significantly to the QS molecules were streaked on SLAD, SLAD + PheOH, and SLAD + TrpOH agar plates (Figure S3). We qualitatively assessed whether there appeared to be more filamentation in the different treatments ([Table 3](#t3){ref-type="table"}) in a manner similar to the study that originally reported the effects of the QS molecules on Σ1278b ([@bib4]). We found that 4 of the 10 strains appeared to respond in the direction predicted, as best as could be detected from visual inspection, but all responses were subtle.

The colonies arising from the streaks on SLAD agar were also compared to the images of the pinned colonies on the SLAD OmniTrays in order to verify that the high throughput method was correctly assessing the overall status of psh ability. While more psh was induced via streaking than pinning, there was clear agreement between the methods: strains with strong psh in one method exhibited strong psh in the other, while non-psh strains did not produce filamentation in either method (Figure S3). However, it is also clear that filamentous index is a rough measurement, as strains that had similar psh induction did not have precisely the same index values. This is likely because all colonies stemming from one OmniTray were analyzed with the same color thresholds. This approach was taken in order to avoid bias, but future work analyzing each colony with its own optimized thresholds could potentially make the filamentous index more accurate. As it is currently being implemented, it appears to be appropriate for assessing general relative psh ability in a large panel.

Natural Genetic Variation in Pseudohyphal Growth {#s16}
------------------------------------------------

In order to investigate the amount of natural segregating genetic variation for psh, an F5 mapping population of YJM311 was phenotyped, and high and low segregants were pooled for sequencing and analysis. Across 24 agar trays, 360 segregants produced 1823 colonies that were scored. The range of phenotypic variation within the mapping population was comparable to that of the 100-genomes collection of environmental strains ([Figure 4B,D](#fig4){ref-type="fig"}): the segregants had an overall mean filamentous index of 13.03 with a median of 11, and the maximum and minimum average filamentous index values were 49.8 and 5, respectively. The pools of segregants used in the sequencing analysis had distinct phenotypic distributions with a high pool mean of 30.32, (standard deviation = 6.45), and a low pool mean of 9.13 (standard deviation = 1.96) ([Figure 4D](#fig4){ref-type="fig"}, insert).

Bulk Segregant Analysis {#s17}
-----------------------

The allele frequencies of the bulk pools were compared using a smoothed-G statistic in order to find chromosomal regions that contain variation associated with psh ([@bib35], Mansfeld *et al.* 2018). Different window sizes for the smoothing function generated a variable number of significant mapping peaks, with windows of 60KB, 40KB, and 20KB producing 4, 26, and 29 significant peaks, respectively, at a false discovery rate of 0.01 ([Figure 5](#fig5){ref-type="fig"}). While a smaller window size is likely to be appropriate for an F5 mapping population, we highlighted candidate genes in the four peaks stemming from the 60KB window, as well as one more on chromosome 14 which just missed the cut-off, as these peaks likely represent major effect loci ([Table 4](#t4){ref-type="table"}). In all five peaks, there were numerous genes that have been shown to either increase or decrease pseudohyphal or invasive growth in the Σ1278b background.

![Genome-wide comparison of the allele frequencies in the high and low psh pools of YJM311 F5 segregants. The G-prime statistic was calculated with a sliding window size of 60,000 bp (A) and 20,000 bp (B). Red line represents the cut-off for significance at a false discovery rate of 0.01. Candidate loci are listed above major, significant peaks.](1533f5){#fig5}

###### Candidate genes from the bulk segregant analysis listed with chromosome, general function, and whether or not there is published data linking the gene to filamentous growth in Σ1278b

  Chr       Gene[*^a^*](#t4n1){ref-type="table-fn"}   Function                      In Σ1278b?[*^b^*](#t4n2){ref-type="table-fn"}   Syn.   Non-Syn.   Reg. (±300bp)
  --------- ----------------------------------------- ----------------------------- ----------------------------------------------- ------ ---------- --------------------------------------
  3         ABP1                                      transcription factor          Yes(1,2)                                        2      1          2
  FIG2      cell adhesin                              Yes(3)                        11                                              18     7          
  CDC39     transcriptional regulator                 Yes(4)                        24                                              10     3          
  5         PEA2                                      polarisome subunit            Yes(1,5,6)                                      2      0          1
  SPI1      cell wall protein                         Yes(5)                        2                                               0      12         
  13        AIM33                                     protein of unknown function   No                                              3      0          6
  ALO1      catalytic enzyme                          Yes(2)                        5                                               0      3          
  YML083C   protein of unknown function               No                            2                                               1      1          
  YML082W   putative protein                          No                            2                                               3      0          
  WAR1      transcription factor                      Yes(2)                        0                                               5      0          
  14        APJ1                                      chaperone                     Yes(2,5)                                        0      5          3
  MKS1      transcriptional regulator                 Yes(2,5,7)                    0                                               0      1          
  MSK1      mito. tRNA synthetase                     Yes(5)                        1                                               7      4          
  FKH2      transcription factor                      Yes(8)                        1                                               8      5          
  SUN4      cell wall protein                         Yes(2,5)                      0                                               5      11         
  GCD10     tRNA methyltransferase                    Yes(5)                        0                                               2      16         
  16        RPS23B                                    ribosomal protein             No, but see 1                                   1      0          8[*^c^*](#t4n3){ref-type="table-fn"}
  TOM5      outer membrane translocase                Yes(9)                        0                                               0      6          
  MEP3      ammonium permease                         Yes(10)                       3                                               0      3          
  KAR3      microtubule motor                         Yes(2)                        2                                               3      1          
  ASN1      Asparagine synthetase                     No                            16                                              3      6          
  YPR148C   protein of unknown function               Yes(2)                        8                                               3      2          

\- For each gene, variation separating the high and low bulks in YJM311 is listed by the number of SNPs in the coding region (synonymous or non-synonymous), and the number of SNPs occurring 300 base pairs upstream and/or downstream of the coding region (possible regulatory variation).

-1-Kang *et al.* (2005), 2-[@bib50], 3-[@bib20], 4-[@bib39], 5-[@bib23], 6-[@bib52], 7-[@bib27], 8-[@bib60], 9-Scherz *et al.* (2014), 10-Lorenz *et al.* (1998).

-includes SNPs in intron.

Discussion {#s18}
==========

Microbes can engage in a myriad of social phenotypes that provide fitness benefits to individuals and genetic lineages ([@bib57]). The model yeast, *S. cerevisiae*, exhibits multiple social phenotypes in the lab, including filamentous growth and quorum sensing. The filamentous growth phenotype appears to be conserved among other *Saccharomyces spp* ([@bib25]) and among medically relevant yeasts, including *Candida albicans* ([@bib9]), other *Candida spp* ([@bib51]), *Asperigillus fumigatus* ([@bib40]) and *Trichosporon asahii* ([@bib10]), with filamentation ranging from pseudohyphae to true hyphae. Thus, filamentous growth is likely an important fungal response to environmental cues. This phenotype can be induced via QS in both *S. cerevisiae* ([@bib4]) and *C. albicans* ([@bib21], [@bib5]), though the QS molecules are not shared.

The goal of this study was to assess the extent of variation in psh and response to external QS molecules in a range of isolates of *S. cerevisiae* in order to understand how the traits vary in natural populations. As such, we were interested in a strong response that is robust to slight environmental fluctuations. Our experimental protocol differed from those used in other studies of psh: we did not use Noble agar (highly purified) or wash cells before plating, and we attempted to quantify the amount of pseudohyphae rather than agar invasion. We also pinned from culture, transferring thousands of cells, rather than streaking to generate colonies from a single cell; our observation is that psh is more extensive when a colony is generated from a single cell (Figure S3). The relative consistency among methods, assays, and replicate plates suggests our results captured the phenotype well, and represents an estimate of the general filamentous response in these environmental strains.

Phenotypic Variation in Pseudohyphal Growth {#s19}
-------------------------------------------

There was a surprising amount of phenotypic variation in the 100-genomes collection, with some strains exhibiting long, pronounced pseudohyphae and some strains having little to no pseudohyphal growth. The image analysis counted a small amount of the white ring of the colony; therefore, values below 10% represent no, or very little, psh. It is possible that if these low strains were assayed in a different manner (*i.e.*, streaked on highly processed medium) more psh would be observed; however, our goal was to assay a general, robust psh response and these strains lacked one.

We hypothesized that clinical strains would exhibit a stronger phenotype due to the association of filamentous growth with biofilm formation and virulence in other yeasts ([@bib12]). However, when the strains were divided into their ecological niche of origin, there did not appear to be a particular niche that had more psh than others. Filamentous growth is likely a more general response and the perceived association with virulence may simply be due to a bias in the organisms in which research is conducted. Another possibility, which is not mutually exclusive, is that *S. cerevisiae* is not adapted to specific ecological niches with regard to this phenotype. Rather, as was previously proposed by [@bib16], it is a "nomad" dispersed among many habitats due to its association with humans. It should be noted that due to the limited number of strains that we analyzed, we were only able to test very broad ecological categories. It is possible that categorizing strains using four general groups obscured the significance of more specific, specialized ecological niches. For example, the fermentation category, which included isolates derived from European wine, Asian sake, African ginger beer, and kefir, could mask important ecological differences associated with the production of these different beverages. Nonetheless, our analysis that divided strains by their population of origin suggested that certain subpopulations are associated with increased psh, specifically, the West African subpopulation. This supports the idea that for this trait, there is a signal based on phylogeny rather than membership in a broad ecological group.

Phenotypic Variation in Response to QS Molecules {#s20}
------------------------------------------------

Based on research in Σ1278b, we hypothesized that some of the low-psh strains would be induced when PheOH and TrpOH were added exogenously. We also hypothesized that fermentation strains would be most sensitive to the QS compounds, as the molecules could disperse further in more viscous environments where QS could be beneficial in synchronizing populations. Furthermore, a recent study investigated the effect of compounds produced during aromatic amino acid metabolism on different wine yeast ([@bib17]). Non-*Saccharomyces* yeast growth was negatively affected by the presence of TrpOH and PheOH, suggesting that these compounds could be particularly important in inter-species interactions in fermentation environments. Surprisingly, most strains in the 100-genomes collection did not respond to the addition of QS molecules to the medium. It is still possible that many of these strains use PheOH and TrpOH for communication, but that the response is too subtle to be detected in our assay (see below). However, if cells do indeed carefully regulate both the production of and the response to QS compounds, it is improbable that exogenous application would have so little detectable effect across a wide panel. At the very least, one would expect a slight change in the same direction in most strains, which is not what was observed. Instead, it is more likely that certain strains respond strongly to PheOH and TrpOH, but most simply do not.

Comparison to **Σ**1278b {#s21}
------------------------

The majority of research on filamentous growth and QS in *S. cerevisiae* has been done on strains derived from Σ1278b, which has proved an invaluable model for understanding the genetic basis of the trait and for generating a robust map of the genetic pathways controlling it ([@bib7]). Homologs of some of the genes implicated in the Σ1278b background have been shown to be important for filamentous growth in other yeast species ([@bib31], [@bib3]). And in the present study, genes uncovered in Σ1278b potentially harbor causative allelic variation in the clinical isolate YJM311.

[@bib4] demonstrated changes in the amount of pseudohyphae produced when Σ1278b was exposed to dilute treatments of PheOH, TrpOH, and both in combination. This strain was included in our panel (well E4), and while it appeared to somewhat respond to one of the autoinducing chemicals (PheOH), our results were not as dramatic as theirs. This is likely because our phenotypic assay was not as sensitive: our analysis measures "fuzziness" around a large colony, so the difference between treatments has to be striking to be detected. When we streaked, rather than pinned Σ1278b, our results were similar to the previously published results (Figure S4), but the amount of change induced is small compared to the range of variation found among environmental isolates. In our assay, we did find individual strains that significantly responded to both chemicals, as was expected. However, in the majority of strains, the results were not as anticipated, and in some cases, were actually the opposite of Σ1278b. It is possible that other strains in our panel could also have a subtle response to the QS compounds, but it is clear that in most strains, the molecules do not induce a dramatic phenotypic change. The difference in inducibility between Σ1278b and the majority of strains in the panel indicates a disparity in behavior between this popular model strain and environmental strains of *Saccharomyces cerevisiae*. Thus, when it comes to QS, the results from the model laboratory strain may not translate smoothly to the broader population of *Saccharomyces* yeasts and how they behave in the environment.

Our results beg the question of why some strains are able to respond to the QS molecules, while others are not. Given the complexity of the filamentous growth response, it is possible that genetic variants exist in all aspects of quorum sensing: some strains may unable to sense the QS molecules, some may sense them, but be unable to respond, and yet others may simply be unable to undergo filamentous growth under any circumstance. While our study did not investigate all of these possibilities, we did investigate natural genetic variation in psh.

Genetic Variation {#s22}
-----------------

The present study aimed to determine whether and how much natural allelic variation existed in psh by using in a heterozygous clinical isolate from the mosaic subpopulation as a proxy. The phenotypic variation in the mapping population recapitulated the variation in the environmental panel, and five major and many minor peaks were associated with the trait, suggesting an abundance of segregating variation for psh in the environment. Complex phenotypes can be strongly influenced by SNPs at non-synonymous, synonymous, and regulatory locations ([@bib49]); all these types of genetic variation were identified in the major mapping peaks of YJM311. We mostly highlighted candidate genes in the peaks that have been implicated in psh in the Σ1278b background, but it is not clear whether or not they contain the causative alleles. These loci influence numerous cellular processes such as cell wall biosynthesis, mitochondrial function ([@bib24]), cell polarity ([@bib52]), progression through the cell cycle ([@bib60]), and ammonium uptake ([@bib33]). While investigating the functional effect of various alleles was beyond the scope of this study, we anticipate future studies could harness the power of this approach.

It is worth noting that a recent study comparing psh in *S. cerevisiae* and *S. bayanus* found that the cyclic AMP-Protein Kinase A pathway plays an important regulatory role in both. However, the manner in which the genetic network regulates the phenotype has diverged: increasing levels of cAMP has the opposite effect on the induction of the phenotype in the two species ([@bib34]). This suggests selection to maintain filamentous growth over a long time scale, but also the ability of the complex genetic network underlying the trait to adapt and change. Future work identifying the genetic basis of some of the phenotypic variation observed in this study could shed light on the components of the genetic network that currently harbor segregating allelic variation, and upon which selection could ultimately act.
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